Pfizer Scientist Dies

Genetics researcher and senior vice president of the pharmaceutical giant, David Cox, has passed away unexpectedly at age 66.

Written byBeth Marie Mole
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

FLICKR, Montgomery County Planning CommissionThe head genetics researcher at Pfizer Corporation’s San Francisco office, David Cox, died unexpectedly, the company announced this week (January 22). He was 66 years old. Cox, a senior vice president who joined in the multinational pharmaceutical company in 2008, was considered a visionary leader in drug development and biotech innovations.

“David Cox was a world-renowned geneticist and a highly valued leader here at Pfizer,” a Pfizer spokeswoman said in a statement, reported by Forbes. “As the company’s lead geneticist based at our Rinat facility in San Francisco, David was a driving force in shaping Pfizer’s strategy on Precision Medicine, as well as our vision for the future of biomedical innovation. Our thoughts and sympathies are with David’s family during this difficult time, and he will be truly missed.”

Before joining Pfizer, Cox trained as a pediatrician and became professor of genetics and pediatrics at Stanford University as well as the co-director of the Stanford Genome Center. After being involved in the project to sequence the human genome, he went on to co-found and become the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies